Alveolar soft-part sarcoma. A report of ten cases.

Journal and index pages often block iframe embedding. This reader keeps the evidence details in Orthonotes and leaves the source page one click away.

Abstract

[Indexed for MEDLINE] 18. J Orthop Surg Res. 2024 Oct 3;19(1):621. doi: 10.1186/s13018-024-05098-9. The clinical outcomes and prognostic factors of dedifferentiated central chondrosarcoma in extremities. Li Z(1)(2)(3), Liu W(4)(5)(6), Hao L(1)(2), Zhang Q(1)(2), Niu X(1)(2). Author information: (1)Peking University Fourth School of Clinical Medicine, Department of Orthopaedic Oncology Surgery, Beijing Jishuitan Hospital, Beijing, 100035, China. (2)National Center for Orthopaedics, Beijing, 100035, China. (3)Beijing Research Institute of Traumatology and Orthopaedics, Beijing, 100035, China. (4)Peking University Fourth School of Clinical Medicine, Department of Orthopaedic Oncology Surgery, Beijing Jishuitan Hospital, Beijing, 100035, China. liuweifengjst@126.com. (5)National Center for Orthopaedics, Beijing, 100035, China. liuweifengjst@126.com. (6)Beijing Research Institute of Traumatology and Orthopaedics, Beijing, 100035, China. liuweifengjst@126.com. OBJECTIVE: This study was to analyze the clinical outcomes and prognostic factors of dedifferentiated central chondrosarcomas (DCCS) in extremities. METHODS: A retrospective study was conducted on 49 patients (27 males, 22 females) who underwent surgical treatment between January 2001 and March 2023 in our institution. All patients were diagnosed with dedifferentiated central chondrosarcomas by needle biopsy or postoperative histopathological examination. The general characters, treatment and clinical outcomes were recorded in the follow-up and all surgical-related complications that occurred were recorded in this study. Overall, these data were used to analyse the prognostic factors of DCCS. RESULTS: 49 patients were included in this retrospective study and there were no patients lost in the follow-up period. The median diagnosis age of all patients was 57 years old (ranging from 17 to 87) and the median follow-up time was 34 months (range, 1-289). The average tumor size was 9.6 ± 2.4 cm (3.0-15.5). Median overall survival (OS) and progression-free survival (PFS) were 34 and 23 months, respectively. The 1-year, 2-year, 5-year, and 10-year OS were 87.8% (95% CI 77.6%-98.0%), 71.4% (35/49), 28.6% (14/49) and 18.4% (9/49). And the 1-year, 2-year, 5-year, and 10-year PFS were 75.5% (95% CI 63.6%-87.4%), 49.0% (35/49), 26.5% (14/49) and 16.3% (9/49). Multiple variate analyses indicated metastasis, pathological fracture, Enneking staging and surgical margin were independent prognostic factors in extremity dedifferentiated central chondrosarcomas. CONCLUSIONS: Dedifferentiated central chondrosarcomas in extremities still had a grave prognosis. Metastasis, pathological fracture, Enneking staging, and surgical margin were independent risk factors for prognosis. EVIDENCE LEVEL: IV Therapic. © 2024. The Author(s). DOI: 10.1186/s13018-024-05098-9 PMCID: PMC11448416